Vanguard Group Inc. decreased its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 2.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,160,897 shares of the company's stock after selling 357,164 shares during the quarter. Vanguard Group Inc. owned 11.61% of Revvity worth $1,273,317,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also recently made changes to their positions in RVTY. EdgePoint Investment Group Inc. grew its holdings in shares of Revvity by 26.3% during the third quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company's stock valued at $751,536,000 after buying an additional 1,784,620 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Revvity by 127.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company's stock valued at $171,921,000 after buying an additional 980,142 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Revvity by 39.0% during the third quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company's stock valued at $186,307,000 after buying an additional 596,436 shares during the last quarter. Neuberger Berman Group LLC grew its holdings in shares of Revvity by 4,598.9% during the third quarter. Neuberger Berman Group LLC now owns 460,447 shares of the company's stock valued at $40,358,000 after buying an additional 450,648 shares during the last quarter. Finally, Diamond Hill Capital Management Inc. purchased a new stake in shares of Revvity during the third quarter valued at approximately $35,206,000. Hedge funds and other institutional investors own 86.65% of the company's stock.
Revvity Trading Up 5.4%
Shares of RVTY stock opened at $86.73 on Friday. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $118.30. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. The firm's 50 day moving average is $90.39 and its 200 day moving average is $96.74. The stock has a market capitalization of $9.70 billion, a P/E ratio of 41.70, a P/E/G ratio of 1.75 and a beta of 1.13.
Revvity (NYSE:RVTY - Get Free Report) last issued its earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The company had revenue of $772.06 million for the quarter, compared to analysts' expectations of $759.81 million. During the same quarter last year, the company posted $1.42 earnings per share. The firm's quarterly revenue was up 5.9% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Research analysts expect that Revvity Inc. will post 5.39 earnings per share for the current year.
Revvity Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be given a $0.07 dividend. The ex-dividend date is Friday, July 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity's dividend payout ratio (DPR) is presently 13.46%.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on RVTY. The Goldman Sachs Group cut their price target on shares of Revvity from $110.00 to $95.00 and set a "neutral" rating on the stock in a report on Tuesday, April 14th. JPMorgan Chase & Co. dropped their target price on shares of Revvity from $105.00 to $96.00 and set a "neutral" rating on the stock in a report on Tuesday, March 31st. Weiss Ratings cut shares of Revvity from a "hold (c-)" rating to a "sell (d+)" rating in a report on Wednesday, March 18th. Jefferies Financial Group raised their target price on shares of Revvity from $100.00 to $105.00 and gave the stock a "hold" rating in a report on Monday, February 2nd. Finally, Barclays restated an "equal weight" rating and issued a $95.00 target price (down from $118.00) on shares of Revvity in a report on Tuesday, April 14th. Three equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Revvity presently has a consensus rating of "Hold" and a consensus target price of $109.73.
View Our Latest Report on Revvity
About Revvity
(
Free Report)
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
See Also
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.